K. Shi
Drug Delivery · with Fang · 2017
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Whom K. Shi trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Vladimir Torchilin (in Molecular Biology)
Papers from K. Shi's perspective
Ordered by how strongly the researchers K. Shi trusts endorse each paper. Same corpus, a different order for every researcher.
- Targeted pharmaceutical nanocarriers for cancer therapy and imaging (AAPS Journal)
- Targeting nanoparticles to cancer. (Pharmacological Research)
- PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles. (European Journal of Cell Biology)
- TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors (Proceedings of the National Academy of Sciences of the United States of America)
- Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers. (Advanced Drug Delivery Reviews)
- Ligand-targeted therapeutics in anticancer therapy (Nature Reviews. Cancer)
- Drug-like properties and the causes of poor solubility and poor permeability. (Journal of pharmacological and toxicological methods)
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.
- Recent advances with liposomes as pharmaceutical carriers (Nature reviews. Drug discovery)
- Biomedical applications of hydrogels: A review of patents and commercial products
Their papers
- Cleavable PEGylation: a strategy for overcoming the “PEG dilemma” in efficient drug delivery (2017) — 322 citations